-
公开(公告)号:US06863693B2
公开(公告)日:2005-03-08
申请号:US10084677
申请日:2002-02-28
IPC分类号: A61L27/00 , A61K31/683 , A61K31/685 , A61K38/00 , A61L27/34 , A61P19/08 , A61F2/28
CPC分类号: A61L27/34
摘要: A prosthesis or implant has a surface carrying a coating comprising at least one phospholipid at a concentration to improve osteointegration. A method of making such a prosthesis or implant and a kit comprising a prosthesis or implant is also described.
摘要翻译: 假体或植入物具有表面,其携带包含至少一种浓度的磷脂的涂层以改善骨整合。 还描述了制造这种假体或植入物的方法和包括假体或植入物的套件。
-
公开(公告)号:US5616602A
公开(公告)日:1997-04-01
申请号:US269416
申请日:1994-06-30
IPC分类号: A61K9/06 , A61K9/127 , A61K31/555 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/22 , A61K47/32 , A61K47/34 , A61K47/38 , A61P17/00 , A61K31/40
CPC分类号: A61K47/20 , A61K31/555 , A61K47/18 , A61K47/22 , A61K9/0014 , A61K9/127 , Y10S514/863
摘要: A topically administrable pharmaceutical composition comprising (A) zinc phthalocyanine complex, (B) as carrier for the complex, (i) a N-alkylpyrrolidone together with a pharmaceutically acceptable co-solvent for the complex, (ii) dimethyl sulphoxide or a mixture thereof with a pharmaceutically acceptable co-solvent for the complex, (iii) a liposome, or (iv) a N,N-dialkylbenzamide or a mixture thereof with a pharmaceutically acceptable co-solvent for the complex, and (C) a gelling agent.
摘要翻译: 一种局部给药的药物组合物,其包含(A)酞菁酞菁络合物,(B)作为络合物的载体,(i)N-烷基吡咯烷酮以及用于络合物的药学上可接受的共溶剂,(ii)二甲基亚砜或其混合物 (iii)脂质体,或(iv)N,N-二烷基苯甲酰胺或其与药学上可接受的助溶剂的混合物,和(C)胶凝剂。
-
公开(公告)号:US07977474B2
公开(公告)日:2011-07-12
申请号:US11571130
申请日:2005-06-22
IPC分类号: C07D487/22 , A61K31/40 , A61K31/44 , A61B5/055
CPC分类号: A61K31/409
摘要: The invention provides the use of a compound of Formula (I), or metallated derivative thereof, in the preparation of a medicament for killing or attenuating the growth of microorganisms by a method which does not comprise exposing the compound to a photodynamic therapy light source or a sonodynamic therapy ultrasound source Formula (I) wherein X1, X2, X3, X4, Yi, Y2, Y3, Y4 and Z have meanings given in the description. Preferably, the microorganisms are selected from the group consisting off bacteria, mycoplasmas, yeasts, fungi and viruses.
摘要翻译: 本发明提供式(I)化合物或其金属化衍生物在制备用于通过不包括将化合物暴露于光动力学治疗光源的方法杀死或减弱微生物生长的药物中的用途,或 其中X1,X2,X3,X4,Yi,Y2,Y3,Y4和Z具有在说明书中给出的含义的声动力学治疗超声波源(I)。 优选地,微生物选自细菌,支原体,酵母,真菌和病毒组成的组。
-
-